Manufacturer's reply
There are published datal' supporting the fact that the creatine kinase (CK) and CK-MB assays from Boehringer Mannheim (BM; now Roche, Mannheim, Germany) are affected by the adenylate kinase activity in haemolysed specimens.
With the current Boehringer Mannheim system kits it is possible to run the CK assay with a rate-blanking procedure; however, this method is affected by haemolysis, as noted in the Boehringer Mannheim Corporation application report for the (BM)/ Hitachi 917. 4 Our experience with the rate-blanking method is that in non-haemolysed samples 'overcompensated' results showing decreased values (approximately 5 U/L) are seen, compared with the non-blanked method. This phenomenon has been observed on both the BM/Hitachi 917 and the BM/Hitachi 902. Occasionally, with heparinized plasma samples, a clearing effect is observed during the first 5 min of the reaction which can also yield incorrect results.
It is for this reason that Boehringer Mannheim (Roche) do not officially recommend the rate-blanking method.
The figure from Parry's letter (above) indicates that the effect for total CK is not significant ( < 20 U/L at 2 gil haemoglobin) which is approximately 10% of the medical decision level.
However, as the CK-MB assay is seriously affected by haemolysis, we take great care to highlight this phenomenon in the kit insert. Operators of BM/Hitachi systems are automatically informed by the use of serum indices about the composition of the sample and, therefore, any likely interference. It is also important to note that if other heart enzymes (lactate dehydrogenase and aspartate aminotransferase) are requested, a haemolysed sample will provide no useful diagnostic data.
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The BM/Hitachi 917 has five user-definable channels. These channels, although not specifically designed for this purpose, may be used for a blanked methodology. Users may also design their own chemistry and have the protocol converted to a closed channel for the cost of a set of bar code labels. This enables users to enjoy all the benefits of the system, such as automatic calibration, bottle change and so on, using their defined parameters. Correspondent's reply
PAUL B LOWRY
The claim of 'overcompensation' in non-haemolyzed samples is interesting since it appears that a false assumption has been made, i.e., that adenylate kinase (AK) originates only from red blood cells. In fact, AK has a wide tissue distribution. The 'overcompensation' of approximately 5 U/L observed with non-haemolysed specimens may in fact represent appropriate compensation for the presence of adenylate kinase from non-red-blood-cell sources. The other issue raised relates to a 'clearing effect' during the first 5 min of reaction. This was first described by Thoedorsen and Stromme I and is related to the development of turbidity in the reaction mixture due to aggregation of heparinprotein complexes. These authors showed that this can be prevented by increasing the ionic strength of the reagents by the addition of sodium chloride. This has been confirmed in our laboratory. In our experiments, we observed that the rate-blanking method gives equivalent results for plasma and serum when sodium chloride is added to reagent I, whereas a marked negative bias is observed for plasma samples when reagent I is not supplemented with sodium chloride.
Our contention remains that the manufacturer can and should supply kits for creatine kinase (CK) and CK-MB analysis with applications that eliminate AK interference from all sources, and that they should consider increasing the 
